Inflammatory Bowel Disease Related Joint Manifestations
1 other identifier
observational
217
0 countries
N/A
Brief Summary
The main purpose of this research is to identify incidence of jiunt manifestations by its both types axial and periphral in IBD patients, its types , relation to IBD activity, lines of treatment using and how they are effective in prevention and in treatment of these joint manifestations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2022
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJanuary 20, 2023
January 1, 2023
1.8 years
December 24, 2022
January 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The joint manifestations in Inflammatory bowel disease patients.
The main purpose of this research is to identify incidence of joint manifestations by its both types axial and peripheral in crohns disease and ulcerative colitis patients, relation to the disease activity,other extra intestinal manifestations, lines of treatment used and how they are effective in prevention and in treatment of these joint manifestations.
2017 to 2024
Eligibility Criteria
patients with inflammatory bowel disease attending IBD clinic in EL-RAGHY LIVERHOSPITAL.
You may qualify if:
- Patients previously diagnosed by colonoscopy and biopsy of IBD either crhons disease or ulcerative colitis from2017 to 2022 attending IBD clinic in EL-RAGHY LIVERHOSPITAL.
You may not qualify if:
- Patients with a known diagnosis of any other joint disease like:
- autoimmune disease like SLE , RA , psoriasis
- Osteoarthritis
- Gouty arthritis
- Malignancy
- Polymyalgia rheumatica
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Voulgari PV. Rheumatological manifestations in inflammatory bowel disease. Ann Gastroenterol. 2011;24(3):173-180.
PMID: 24713717BACKGROUNDFragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World J Gastroenterol. 2019 May 14;25(18):2162-2176. doi: 10.3748/wjg.v25.i18.2162.
PMID: 31143068BACKGROUNDDi Carlo M, Luchetti MM, Benfaremo D, Di Donato E, Mosca P, Maltoni S, Benedetti A, Gabrielli A, Grassi W, Salaffi F. The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis. Clin Rheumatol. 2018 Apr;37(4):1037-1044. doi: 10.1007/s10067-017-3937-6. Epub 2017 Dec 4.
PMID: 29204760BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed Ali, ass.prof doc
assiut univeristy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
December 24, 2022
First Posted
January 20, 2023
Study Start
March 1, 2023
Primary Completion
December 31, 2024
Study Completion
March 1, 2025
Last Updated
January 20, 2023
Record last verified: 2023-01